European Hematology Association / X
Jul 2, 2025, 18:14
From Milan with Insights: EHA 2025 Perspectives Congress Reports Now Available Online
European Hematology Association recently shared reports from EHA 2025 Congress on X:
”The EHA Perspectives Congress Reports are now available! Capturing the most important scientific developments and clinical insights presented during EHA 2025 in Milan, we are proud to bring you the latest on AI, hemoglobinopathies, and precision medicine in two reports:
• EHA Perspectives on Malignant Hematology
• EHA Perspectives on Non-malignant Hematology
Whether you’re just starting your journey in hematology or you are a seasoned professional, this comprehensive report offers valuable knowledge to support your continued growth and practice.”
Read the EHA Perspectives Congress Reports here.
EHA has released its much-anticipated Perspectives Congress Reports, spotlighting the most impactful scientific advances and clinical insights presented in Milan.
Covering a broad spectrum—from breakthroughs in AI applications to updates on hemoglobinopathies and the growing role of precision medicine—these publications aim to refine the essence of the EHA 2025 Congress into accessible, practice-informing takeaways.
Find more takeaways from global conferences and congresses in Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia